“RENAL AND HEPATIC IMPAIRMENT BROUGHT ON BY CISPLATIN WITHOUT COMPROMISING ANTICANCER EFFICACY”. 2024. Romanian Journal of Diabetes, Nutrition and Metabolic Diseases 31 (1): 394-406. https://jrdiabet.ro/index.php/RJDNMD/article/view/307.